Immune reset: the approach that could leave therapies for treating autoimmune diseases behind
The immune reboot proposes to reorganize and balance the immune system in autoimmunity through specialized therapies that seek real cures.
What is immune reset and why does it matter
The immune reset is an emerging scientific approach that seeks to restore the balance of the immune system in people with autoimmune diseases, rather than simply controlling symptoms with traditional immunosuppressants. This idea was proposed in a recently published article by Dr. John Isaacs, a professor of rheumatology at Newcastle University, in Nature Reviews Rheumatology.
In the context of autoimmunity, the immune system mistakenly attacks the body's own tissues, as occurs in rheumatoid arthritis, lupus, or multiple sclerosis, causing chronic inflammation and progressive damage. Conventional treatments globally suppress immune activity and may relieve symptoms, but they increase the risk of infections and do not always prevent disease progression.
The concept of immune reset presents a more specific alternative: eliminating or reprogramming specific cell groups, such as autoreactive B cells or defective T cells, so that the immune system stops attacking its own tissues and regains its natural regulatory function.
How a real immune system reset would work
In practical terms, immune reset is not a single technique, but a collection of advanced therapeutic strategies designed to "reset" the way the body recognizes self and non-self:
- One research avenue involves administering therapies that eliminate pathogenic B cells that contribute to autoimmune damage, similar to restarting a computer by clearing harmful processes.
- Another approach uses tolerogenic dendritic cells (TolDC), programmed to teach the immune system not to attack healthy tissues. These cells are extracted, cultured, and reintroduced into the patient to promote tolerance.
- Methods based on regulatory T cells (Tregs) or even advanced CAR-T type gene therapies and cell modification are also being explored, focused on restoring immune self-protection.
These procedures, together, aim for a thorough review of the immune system rather than superficial controls of inflammation. Researchers suggest that identifying precise biomarkers will be key to differentiating a healthy immune system from an altered one and assessing the effectiveness of these interventions.
Initial results and clinical challenges
Initial trials with tolerogenic dendritic cells have shown that this approach is safe and well-tolerated in people with rheumatoid arthritis, although clarity on its long-term efficacy is still lacking. Scientists are defining what doses and routes of administration are optimal, as well as how to reliably measure the actual clinical and immunological impact of these therapies.
A central challenge is to demonstrate that an immune reset not only controls symptoms transiently but produces a lasting remission without relapses or serious side effects. This requires the validation of robust immunological markers and prolonged follow-up of patients.
Moreover, although preliminary data is promising, many experts warn that these therapies are still in early stages of development and should not be considered curative without solid evidence of widespread efficacy. This caution is especially important because autoimmune diseases encompass over a hundred pathologies with very diverse mechanisms and manifestations.
Compared to current treatments: what changes?
Current treatments for autoimmunity, such as corticosteroids or immunosuppressants, work by suppressing much of the immune system's activity to reduce inflammation. These can be effective, but they carry risks of infections, cancer, or cardiovascular problems in the long term.
The immune reset, by targeting the underlying causes of autoimmunity more specifically —such as defective cells or erroneous immune signals— could offer more lasting benefits and fewer adverse effects. In some experimental scenarios and early-stage trials, this type of intervention has been observed to modulate the disease more stably than conventional treatments, although broad confirmation in large clinical studies is still needed.
Potential applications beyond one disease
Although much of the research focuses on conditions like rheumatoid arthritis, scientists believe that the principles of immune reset could be applied to other significant autoimmune diseases, such as type 1 diabetes or multiple sclerosis, if trials can demonstrate consistent positive effects.
Larger and integrated studies also explore how these methods could interact with other emerging immunological technologies, such as advanced cell therapies, reverse vaccines, and genetic engineering strategies, to expand the therapeutic impact on chronic diseases whose traditional management has been limited.
Future perspectives: towards a real cure?
Although there is still a long way to go, many researchers believe that the concept of immune reset represents a transformation of immunological therapy. Where the goal was once to suppress the immune response, now the aim is to restore its natural balance, correcting the causes of the autoimmune response.
If these approaches continue to evolve and demonstrate efficacy and safety in large trials, they could radically change the treatment of chronic autoimmune diseases and offer options that significantly reduce the need for lifelong therapies.